TerminatedPhase 4NCT01694069

Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
West Virginia University
Principal Investigator
Lisa Biondo, PharmD
West Virginia University Healthcare
Intervention
Piperacillin-tazobactam combination product(drug)
Enrollment
6 enrolled
Eligibility
8 years · All sexes
Timeline
2012 – 2013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01694069 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis →

← Back to all trials